Trials / Conditions / Inherited Erythromelalgia
Inherited Erythromelalgia
3 registered clinical trials studyying Inherited Erythromelalgia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Evaluation Of The Efficacy And Safety Of Single Doses Of PF-05089771 In Patients With Primary (Inherited) Eryt NCT01769274 | Pfizer | Phase 2 |
| Completed | Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in NCT01486446 | Xenon Pharmaceuticals Inc. | Phase 1 / Phase 2 |
| Completed | Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM) NCT01090622 | Xenon Pharmaceuticals Inc. | Phase 1 / Phase 2 |